Jiangsu Nutai Biologics Co., Ltd
Clinical trials sponsored by Jiangsu Nutai Biologics Co., Ltd, explained in plain language.
-
New DNA therapy aims to fight cancer and wasting in late-stage patients
Disease control Recruiting nowThis early-phase study tests a new DNA-based medicine called SXRN in 28 people with advanced solid tumors who have not responded to standard treatments. The main goals are to check safety and find the best dose, while also seeing if it can improve appetite and physical function. …
Phase: EARLY_PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
New shot aims to help cancer patients eat and gain weight
Symptom relief Recruiting nowThis early-stage study tests a new injection called SXRN in 54 adults with advanced cancer who are losing weight and appetite. The goal is to find a safe dose and see if it helps improve appetite and weight. Participants will receive the drug alone or with standard cancer treatme…
Phase: PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC